alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```
[Federal Register Volume 62, Number 146 (Wednesday, July 30, 1997)]
[Notices]
[Page 40809]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-20021]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Bonneville Power Administration

Notice of Availability of Record of Decision to Execute a Power 
Purchase Agreement for the Wyoming Wind Plant Project

AGENCY: Bonneville Power Administration (BPA), Department of Energy 
(DOE).

ACTION: Notice of availability of Record of Decision (ROD).

-----------------------------------------------------------------------

SUMMARY: BPA has decided to execute a Power Purchase Agreement (PPA) to 
acquire a 15.32 megawatt (MW) share of nominal project capacity from 
the Wyoming Wind Plant Project (Project). This PPA will allow BPA to: 
(1) Test the ability of wind energy to provide a reliable, economical, 
and environmentally acceptable energy resource; (2) assure consistency 
with BPA's statutory responsibilities; and (3) assure consistency with 
BPA's April 22, 1993, Resource Programs ROD. This notice announces the 
availability of the ROD to execute the PPA, relying on the Kenetech/
PacifiCorp Windpower Project Environmental Impact Statement (Project 
EIS) (DOE/EIS-0255 August, 1995). Because the Bureau of Land Management 
(BLM) has jurisdiction over part of the land on which the Wyoming Wind 
Plant Project will be located, it was the lead agency on the EIS. BPA, 
as a cooperating agency with the BLM, adopts the Project EIS in this 
ROD.

ADDRESSES: Copies of the ROD and Project EIS may be obtained by calling 
BPA's toll-free document request line: 1-800-622-4520.

FOR FURTHER INFORMATION, CONTACT: Kathy Fisher--ECP, Environmental 
Project Lead, Bonneville Power Administration, P.O. Box 3621, Portland, 
Oregon, 97208-3621, phone number (503) 230-4375, fax number (503) 230-
5699.

    Issued in Portland, Oregon, on July 21, 1997.
Randall W. Hardy,
Administrator and Chief Executive Officer.
[FR Doc. 97-20021 Filed 7-29-97; 8:45 am]
BILLING CODE 6450-01-P
```
# C_2015146EN.01000701.xml

| 4.5.2015 | EN | Official Journal of the European Union | C 146/7 |
| --- | --- | --- | --- |

4.5.2015

EN

Official Journal of the European Union

C 146/7

---

Order of the Court (Seventh Chamber) of 22 January 2015 — GRE Grand River Enterprises Deutschland GmbH v Office for Harmonisation in the Internal Market (Trade Marks and Designs), Villiger Söhne GmbH

(Case C-495/13 P) (1)

1

((Appeal - Community trade mark - Regulation (EC) No 40/94 - Article 8(1)(b) - Figurative mark in colour, consisting of the verbal components ‘LIBERTE american blend’ on a red background - Opposition by the holder of the Community trade mark ‘La LIBERTAD’ - Refusal of registration))

(2015/C 146/09)

Language of the case: German

Parties

Parties

Appellant: GRE Grand River Enterprises Deutschland GmbH (represented by: I. Memmler and S. Schultz, Rechtsanwältinnen)

Appellant:

Other parties to the proceedings: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: D. Walicka, Agent), Villiger Söhne GmbH (represented by: B. Pikolin, Rechtsanwätin)

Other parties to the proceedings:

Operative part of the order

Operative part of the order

| 1. | The appeal is dismissed. |
| --- | --- |

1.

The appeal is dismissed.

| 2. | GRE Grand River Enterprises Deutschland GmbH is ordered to pay the costs. |
| --- | --- |

2.

GRE Grand River Enterprises Deutschland GmbH is ordered to pay the costs.

---

(1)  OJ C 325, 9.11.2013.

1

---
Exhibit 32.2

                           INTRAOP MEDICAL CORPORATION

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Intraop Medical Corporation (the
"Company") on Form 10-QSB/A for the period ending March 31, 2005, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Howard Solovei, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

(3)  The Report fully complies with the requirements of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

(4)  The information contained in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the Company.


                                               /s/ Howard Solovei
                                             -----------------------------------
                                                 Howard Solovei
                                                 Chief Financial Officer

                                                 Date:  August 12, 2005

A signed original of this written statement required by Section 906 has been
provided to Intraop Medical Corporation and will be retained by Intraop Medical
Corporation and furnished to the Securities and Exchange Commission or its staff
upon request.
<TABLE> <S> <C>



                            
<ARTICLE>                                         9
<LEGEND>
     This schedule contains summary financial information extracted from
     the Form 10-K for the year ended December 31, 1998 and is qualified
     in its entirety by reference to such financial statements and
     accompanying disclosures.
</LEGEND>
       
<S>                                                <C>

<PERIOD-TYPE>                                  Year
<FISCAL-YEAR-END>                              Dec-31-1998
<PERIOD-END>                                   Dec-31-1998
<CASH>                                         11,239
<INT-BEARING-DEPOSITS>                         0
<FED-FUNDS-SOLD>                               20,085
<TRADING-ASSETS>                               0
<INVESTMENTS-HELD-FOR-SALE>                    35,216
<INVESTMENTS-CARRYING>                         11,173
<INVESTMENTS-MARKET>                           13,843
<LOANS>                                        261,380
<ALLOWANCE>                                    (4,778)
<TOTAL-ASSETS>                                 349,934
<DEPOSITS>                                     302,442
<SHORT-TERM>                                   5,000
<LIABILITIES-OTHER>                            6,188
<LONG-TERM>                                    0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       16,776
<OTHER-SE>                                     18,706
<TOTAL-LIABILITIES-AND-EQUITY>                 349,934
<INTEREST-LOAN>                                24,858
<INTEREST-INVEST>                              4,482
<INTEREST-OTHER>                               (9)
<INTEREST-TOTAL>                               29,331
<INTEREST-DEPOSIT>                             8,766
<INTEREST-EXPENSE>                             9,077
<INTEREST-INCOME-NET>                          20,254
<LOAN-LOSSES>                                  300
<SECURITIES-GAINS>                             (4)
<EXPENSE-OTHER>                                11,497
<INCOME-PRETAX>                                9,516
<INCOME-PRE-EXTRAORDINARY>                     9,516
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   5,541
<EPS-PRIMARY>                                  2.23
<EPS-DILUTED>                                  2.11
<YIELD-ACTUAL>                                 .065
<LOANS-NON>                                    360
<LOANS-PAST>                                   1
<LOANS-TROUBLED>                               63
<LOANS-PROBLEM>                                0
<ALLOWANCE-OPEN>                               4,493
<CHARGE-OFFS>                                  288
<RECOVERIES>                                   71
<ALLOWANCE-CLOSE>                              4,778
<ALLOWANCE-DOMESTIC>                           3,513
<ALLOWANCE-FOREIGN>                            0
<ALLOWANCE-UNALLOCATED>                        1,265
        


</TABLE>
# Fourth Court of Appeals

**San Antonio, Tex as** 

November 15, 2019

No. 04

- 19

- 00790

- CV

IN RE Joshua KARLIN

Original Mandamus Proceeding 1

ORDER

Sitting: Sandee Bryan Marion, Chief Justice

Patricia O. Alvarez , Justice

Beth Watkins , Justice

On November 7 , 20 1 9 , relator filed a petition for writ of mandamus

. This court believe s

a serious question concerning the mandamus relief sought requires further consideration. See

T EX

. R. A PP

. P. 52.8(b). The respondent and the real part y in interest may file a response to the

petition in t his court no later than December 2, 2019

. Any s uch response must conform to

Texas Rule of Appellate Procedure 52.4.

It is so ORDERED on November 15, 2019

.

PER CURIAM

ATT ESTED TO: _____________________________

Michael A. Cruz,

Clerk of Court

1 This proceeding ari ses out of Cause No. 2015CI08588 , styled In the Interest of K.G.K., a Child , pending in the

408th Judicial District Court

, Bexar County, Texas, the Honorab le Laura Salinas presiding.
2007 Non-Employee Director Fees( Revised)



 EXHIBIT 10.3 
 2007 DIRECTOR FEES 
 (Revised to include a fee for the Non-Executive Chairman) 
  

			
	Retainer Fee:	  	 $172,000/per year
 Cash: $86,000
 Stock Options: $43,000
 Deferred Stock Units*: $43,000

		
	Non-Executive Chairman of the Board Fee**:	  	$200,000/per year in Deferred Stock Units
		
	Committee Chair Fee for Compensation, CGC and Finance Committees:	  	$10,000/per year
		
	Audit Committee Chair Fee:	  	$20,000/per year
		
	Audit Committee Member Retainer Fee:	  	$5,000/per year
		
	Lead Director Retainer Fee:	  	$25,000/per year



	*	Deferred Stock Units are “phantom” units of LNC Common Stock that are credited under the LNC Directors’ Deferred Compensation Plan. 


	**	J. Patrick Barrett was appointed Non-executive Chairman in July 2007. Accordingly, he is receiving a pro-rated fee in 2007. 

 All cash fees may be deferred, at a Director’s election, pursuant to the LNC Directors’ Deferred Compensation Plan. 
 Meeting fees may be paid in some cases for meetings which exceed the number of annually scheduled meetings ($1,100 per meeting) as determined by the Corporate Governance
Committee. 
 All fees are paid to the directors on a quarterly basis in arrears.
EX-10.1






Exhibit 10.1




AMENDMENT NO. 2 TO

EMPLOYMENT AGREEMENT




THIS AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (“Amendment”) is made this sixth day of November
2007, between NVR, INC., a Virginia corporation (the “Company”) and DWIGHT C. SCHAR, (the
“Executive”). References within this Amendment to the Company refer to NVR and its subsidiaries
and affiliates.



WHEREAS, the parties wish to amend that Employment Agreement entered into between the Company and
the Executive date July 1, 2005, which was subsequently amended by Amendment No. 1 on December 21,
2006 (“Employment Agreement”); and



WHEREAS, Section 8.3 of the Employment Agreement states that amendments shall only be effectuated
pursuant to a written instrument signed by both parties to the Employment Agreement;



WHEREAS, the Company and the Executive find it desirous to execute an Amendment, whereby the
Executive’s base salary and bonus opportunity for calendar year 2008 is $0.



ACCORDINGLY, for and in consideration of the foregoing and of the mutual covenants and agreement
set forth in this Amendment, the parties AGREE as follows:




	1.	 	Paragraph 3.1 of the Employment Agreement is hereby amended and restated in its entirety as
follows:






As compensation for all services rendered pursuant to this Agreement, the Company will pay
to the Executive an annual base salary of ONE MILLION FIVE HUNDRED THOUSAND DOLLARS
($1,500,000) payable in equal monthly installments of ONE HUNDRED TWENTY-FIVE THOUSAND
DOLLARS ($125,000). For calendar year 2008 only, (i) the Executive’s annual base salary is
equal to $0, and (ii) the Executive’s annual base salary for purposes of calculating any
payments due the Executive pursuant to Section 6 of the Agreement shall be deemed to be
$1,500,000, provided that the Company may make any adjustments to the Executive’s 2008 base
salary up to $1,500,000 to the extent necessary to avoid unintended consequences under the
Employment Retirement Income Security Act, the Internal Revenue Code, the Company’s benefit
plans or other similar laws and arrangements. The Company’s Board of Directors in its sole
discretion may increase, but may not reduce, the Executive’s annual base salary.




	2.	 	Except as expressly provided herein, the terms and conditions of the Employment Agreement, as
amended, shall remain in full force and effect and shall be binding on the parties hereto.





IN WITNESS WHEREOF, the parties have duly executed and delivered this Amendment, or have
caused this Amendment to be duly executed and delivered in their name and on their behalf,
intending to be legally bound by its terms, as of the day and year first above written.



NVR, INC.



	 	 	 
	By:/s/ Robert M. Paul

	 	/s/ Dwight C. Schar
	 

	 	 
	
 
	 	DWIGHT C. SCHAR
Before The Third Division,

April 26, 1943

No. 48234.

#### Petition 6350-R of Jenkins Bros. (New York).

Opinion by

Cline, J.

The petition was dismissed.
Exhibit 23

                 Consent of Independent Public Accountants

    As independent public accountants, we hereby consent to the
incorporation by reference of our report for Thermedics Inc. dated
February 12, 1998, included in or made a part of this Form 10-K, into the
Company's previously filed Registration Statement No. 2-93746 on Form S-8,
Registration Statement No. 33-00183 on Form S-8, Registration Statement
No. 2-93747 on Form S-8, Registration Statement No. 33-8992 on Form S-8,
Registration Statement No. 33-31621 on Form S-8, Registration Statement
No. 33-9215 on Form S-8, Registration Statement No. 33-43707 on Form S-3,
Registration Statement No. 33-40866 on Form S-3, Registration Statement
No. 33-64070 on Form S-8, Registration Statement No. 33-86972 on Form S-8,
Registration Statement No. 33-86974 on Form S-8, Registration Statement
No. 033-65279 on Form S-8, Registration Statement No. 033-61435 on Form
S-8, Registration No. 333-2149 on Form S-3, and Registration No. 333-32035
on Form S-3.



                                               Arthur Andersen LLP



Boston, Massachusetts
February 11, 1999
II 

Calendar No. 318 

112TH CONGRESS 

2D SESSION S. 2079 

To extend the pay limitation for Members of Congress and Federal employees. 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 7, 2012 

Mr. HELLER introduced the following bill; which was read the first time 

FEBRUARY 9, 2012 

Read the second time and placed on the calendar 

A BILL 

To extend the pay limitation for Members of Congress and 

Federal employees. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. EXTENSION OF PAY LIMITATION. 

4 (a) IN GENERAL.—Section 147 of the Continuing 

5 Appropriations Act, 2011 (Public Law 111–242; 5 U.S.C. 

6 5303 note), as added by section 1(a) of the Continuing 

7 Appropriations and Surface Transportation Extensions 


smartinez on DSK6TPTVN1PROD with BILLS
2 

•S 2079 PCS

1 Act, 2011 (Public Law 111–322; 124 Stat. 3518), is 

2 amended— 

3 (1) in subsection (b)(1), by striking ‘‘December 

4 31, 2012’’ and inserting ‘‘December 31, 2013’’; and 

5 (2) in subsection (c), by striking ‘‘December 31, 

6 2012’’ and inserting ‘‘December 31, 2013’’. 

7 (b) APPLICATION TO LEGISLATIVE BRANCH.— 

8 (1) MEMBERS OF CONGRESS.—The extension of 

9 the pay limit for Federal employees through Decem10 ber 31, 2013, as established pursuant to the amend11 ments made by subsection (a), shall apply to Mem12 bers of Congress in accordance with section 601(a) 

13 of the Legislative Reorganization Act of 1946 (2 

14 U.S.C. 31). 

15 (2) OTHER LEGISLATIVE BRANCH EMPLOY16 EES.— 

17 (A) LIMIT IN PAY.—Notwithstanding any 

18 other provision of law, no cost of living adjust19 ment required by statute with respect to a legis20 lative branch employee which (but for this sub21 paragraph) would otherwise take effect during 

22 the period beginning on the date of enactment 

23 of this Act and ending on December 31, 2013, 

24 shall be made. 


smartinez on DSK6TPTVN1PROD with BILLS
3 

•S 2079 PCS

1 (B) DEFINITION.—In this paragraph, the 

2 term ‘‘legislative branch employee’’ means— 

3 (i) an employee of the Federal Gov4 ernment whose pay is disbursed by the 

5 Secretary of the Senate or the Chief Ad6 ministrative Officer of the House of Rep7 resentatives; and 

8 (ii) an employee of any office of the 

9 legislative branch who is not described in 

10 clause (i). 


smartinez on DSK6TPTVN1PROD with BILLS
Calendar No. 318 

112TH CONGRESS 

2D SESSION S. 2079 

A BILL 

To extend the pay limitation for Members of 

Congress and Federal employees. 

FEBRUARY 9, 2012 

Read the second time and placed on the calendar 


smartinez on DSK6TPTVN1PROD with BILLS
EXHIBIT 23



             Consent of Independent Certified Public Accountants



       We have issued our report dated April 20, 2001, accompanying the
       financial statements included in the Annual Report of CompuTrac,
       Inc.  on  Form  10-KSB  for the year ended January 31, 2001.  We
       hereby consent to the incorporation by  reference of said report
       in  the Registration Statements of CompuTrac, Inc. on   Form S-8
       (File Nos. 33-40732;  33-40734;  33-02906;  33-07319; 33-61577).


       GRANT THORNTON LLP

       Dallas, Texas
       May 11, 2001
<PAGE>
                                                                    EXHIBIT 23.1





                    CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS



As independent public accountants, we hereby consent to the incorporation by
reference of our reports dated January 29, 2002 included in this Form 10-K into
the Company's previously filed Registration Statement File No. 33-31556, No.
33-69840, No. 33-56693, No. 333-34249, No. 333-47729, No. 333-62629, No.
333-76633, No. 333-76635, No. 333-80091, No. 333-40734 and No. 333-65912.



ARTHUR ANDERSEN LLP

Houston, Texas
March 18, 2002
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

MARGARITO LUCAS RODAS-LOPEZ,

 Petitioner,

 v.

ERIC H. HOLDER, Jr., Attorney General,

 Respondent.

No. 11-70391

Agency No. A095-605-013

MEMORANDUM*

On Petition for Review of an Order of the

Board of Immigration Appeals

Submitted November 18, 2014**

Before: LEAVY, FISHER, and N.R. SMITH, Circuit Judges.

Margarito Lucas Rodas-Lopez, a native and citizen of Guatemala, petitions

for review of the Board of Immigration Appeals’ (“BIA”) order dismissing his

appeal from an immigration judge’s decision denying his application for

withholding of removal. We have jurisdiction under 8 U.S.C. § 1252. We review

for substantial evidence the agency’s factual findings, Wakkary v. Holder, 558 F.3d

FILED

NOV 24 2014

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS

 * This disposition is not appropriate for publication and is not precedent

except as provided by 9th Cir. R. 36-3.
1049, 1056 (9th Cir. 2009), and we deny the petition for review.

Substantial evidence supports the BIA’s determination that even though

Rodas-Lopez suffered past persecution by guerrillas in 1992, his presumption of a

fear of future persecution was rebutted by evidence of a fundamental change in

circumstances in Guatemala based on the 1996 peace accords between the

guerrillas and the Guatemalan government. See 8 C.F.R. § 1208.16(b)(1)(i)(A);

see also Gonzalez-Hernandez v. Ashcroft, 336 F.3d 995, 1000-01 (9th Cir. 2003)

(upholding BIA’s finding that petitioner’s presumption was rebutted). We reject

Rodas-Lopez’s contention that the BIA failed to conduct an individualized analysis

of how the changed circumstances affected his specific situation. See Sowe v.

Mukasey, 538 F.3d 1281, 1286 (9th Cir. 2008). In light of our conclusions, we do

not reach Rodas-Lopez’s contention regarding his brother and brother-in-law. 

Finally, we reject Rodas-Lopez’s contention that the BIA erred in its discussion of

the 2003 incident at his parents’ home. Rodas-Lopez did not argue, and does not

contend before the court, that the 2003 incident was “closely tied” to his

mistreatment by guerrillas in 1992. See Arriaga-Barrientos v. INS, 937 F.2d 411,

414 (9th Cir. 1991).

PETITION FOR REVIEW DENIED.

2 11-70391
No. 42035.

#### Protest 940829-G of Madeira Linen Importing Co. (New York).

*368Opinion by

Kinchelos, J.

It was stipulated that the merchandise consists of table covers in chief value of cotton the same as those the subject of *Tausend*v. *United Stales*(T. D. 46636). The claim at 40 percent under paragraph 923 was therefore sustained.
Exhibit 32.1

 

CERTIFICATION PURSUANT TO18 U.S.C. Section 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of **FirstBingo.com** (the "Company") on Form 10-QSB for the period ended **September 30, 2004** as filed with the Securities and Exchange Commission on the date here of (the "report"), I, Richard L. Wachter, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)     The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)     The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated this 15th day of November, 2004.

 
/s/ Richard L. Wachter 
Richard L. Wachter 
Chief Financial Officer
**CONSENT
        OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**
  The
        Board
        of Directors
  Bioanalytical
        Systems, Inc.
  We
        consent to the incorporation by reference in the Registration Statements
        (Nos.
        333-56123 and 333-56127) on Form S-8 of Bioanalytical Systems, Inc. and
        subsidiaries of our report dated December 27, 2007, with respect to the
        consolidated balance sheets of Bioanalytical Systems, Inc. as of September
        30,
        2007 and 2006, and the related consolidated statement of operations,
        shareholders’ equity and comprehensive income (loss), and cash flows for the
        years then ended appearing in this Annual Report on Form 10-K of Bioanalytical
        Systems, Inc. and subsidiaries for the year ended September 30,
        2007.
 
 
 Crowe
        Chizek and Company LLC
 Indianapolis,
        IN
 December
        27, 2007